The FDA has withdrawn its accelerated approval of Krazati (adagrasib) combined with Erbitux (cetuximab) for adults with KRAS G12C-mutated colorectal cancer that is locally advanced or has spread to ...

CURE ® readers have a unique opportunity each year to honor oncology nurses who have helped guide them through the cancer experience. Many thoughtful nomination essays are prepared and submitted by ...

For patients receiving chemotherapy for aggressive lymphoma, we may see lower blood counts, which can increase the risk of infection. Some patients may need blood or platelet transfusions. Hair loss ...

Dr. Diego Schaps discussed how upcoming Medicare competitive bidding changes could affect access to ostomy supplies and why having the right pouching system matters for patients.

Actor and advocate Mariska Hargitay has partnered with Bristol Myers Squibb on "Investigating Myeloma," a disease awareness ...